Skip to main content

Mainolfi Nello's Form 4 filing

Kymera Therapeutics, Inc. (KYMR) · filed Jan 12, 2022

Accession no.
0000899243-22-001807
Filed
Jan 12, 2022
Trade date
Jan 10-12, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 14 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.56M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mainolfi NelloCIK 0001821189Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 10, 2022Common StockMOption exerciseAcquired+22,465$2.08+$46,727.2494,664Direct
Jan 10, 2022Common StockSSaleDisposed−7,485$52.46F2−$392,663.1487,179Direct
Jan 10, 2022Common StockSSaleDisposed−10,673$53.35F3−$569,404.55476,506Direct
Jan 10, 2022Common StockSSaleDisposed−4,201$54.40F4−$228,534.4472,305Direct
Jan 10, 2022Common StockSSaleDisposed−106$54.99−$5,828.94472,199Direct
Jan 11, 2022Common StockMOption exerciseAcquired+16,923$2.08+$35,199.84489,122Direct
Jan 11, 2022Common StockSSaleDisposed−9,932$53.68F5−$533,149.76479,190Direct
Jan 11, 2022Common StockSSaleDisposed−6,644$54.42F6−$361,566.48472,546Direct
Jan 11, 2022Common StockSSaleDisposed−347$55.05F7−$19,102.35472,199Direct
Jan 12, 2022Common StockMOption exerciseAcquired+8,612$2.08+$17,912.96480,811Direct
Jan 12, 2022Common StockSSaleDisposed−2,726$51.31F8−$139,871.06478,085Direct
Jan 12, 2022Common StockSSaleDisposed−4,022$52.02F9−$209,224.44474,063Direct
Jan 12, 2022Common StockSSaleDisposed−1,623$53.27F10−$86,457.21472,440Direct
Jan 12, 2022Common StockSSaleDisposed−241$53.97−$13,006.77472,199Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 10, 2022Common StockMOption exerciseDisposed−22,465$0.00$0599,815Direct
Jan 11, 2022Common StockMOption exerciseDisposed−16,923$0.00$0582,892Direct
Jan 12, 2022Common StockMOption exerciseDisposed−8,612$0.00$0574,280Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.99 to $52.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.99 to $53.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.99 to $54.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.01 to $54.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.01 to $54.995. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.05 to $55.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.60 to $51.575. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.60 to $52.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.88 to $53.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)